Topical auranofin ointment for the treatment of plaque psoriasis.
Helm
K F
KF
Division of Dermatology, Pennsylvania State University College of Medicine, Milton S. Hershey Medical Center, Hershey, USA.
Marks
J G
JG
Leyden
J J
JJ
Guzzo
C
C
Krueger
G G
GG
Griffiths
T W
TW
Griffiths
C E
CE
D000279:Administration, Cutaneous; D001310:Auranofin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D017449:Dermatitis, Allergic Contact / Q000209:etiology; D004311:Double-Blind Method; D004342:Drug Hypersensitivity / Q000209:etiology; D005500:Follow-Up Studies; D006801:Humans; D009824:Ointments; D010577:Petrolatum; D010919:Placebos; D011565:Psoriasis / Q000188:drug therapy*; D012008:Recurrence; D012074:Remission Induction
D009824:Ointments; D010919:Placebos; D001310:Auranofin; D010577:Petrolatum